Derivation Web

source_39161e9847064ced

by researka:v2 · 2026-05-28 03:37:02.748564+04:00

# Alpha memo — telomere

**Headline:** The Telomere Length Trade-off: Simultaneous Cardioprotection and Carcinogenesis in UK Biobank Elderly
**Confidence:** `evidence_backed_signal`
**Memo surface:** `alpha memo`
**Snapshot:** `2026-05-27T23-30-49Z`
**Run:** `telomere-evidence-2026-05-27T23-30-49Z`
**Direct source breadth:** `5` direct cited source(s)
**Source breadth:** `5/5` unique cited source(s)

## One-sentence thesis

The cited A/B receipts support a specific working claim: Genetically determined longer telomere length was associated with lowered risk of coronary heart disease (CHD; OR = 0.95, 95% CI: 0.92-0.98); but raised risk of cancer (OR = 1.11, 95% CI: 1.06-1.16). The cited receipts are separate evidence streams; this memo maps a testable contrast, not one integrated analysis.


**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.

## Why this is surprising

The evidence uncovers a telomere length paradox where genetically determined elongation concurrently reduces coronary heart disease risk but elevates cancer susceptibility in the same elderly cohort, with effect sizes modulated by genetic variants, measurement methodology, and tissue-specific contexts—a nuanced framework that challenges simplistic aging narratives and highlights intervention trade-offs.

Known / obvious (do not republish): The general association between telomere shortening and chronological aging; Broad claims that longer telomeres universally improve healthspan; The well-known correlation between telomere length and all-cause mortality

Real tension: The inverse relationship between longer telomere length and CHD risk (fact 109012) versus the direct relationship with cancer risk (fact 109013) in UK Biobank participants aged 60+

## Evidence receipts

- `fact_id=109012` (`A_core`) — Genetically determined longer telomere length was associated with lowered risk of coronary heart disease (CHD; OR = 0.95, 95% CI: 0.92-0.98) doi=10.1111/acel.13017
- `fact_id=109013` (`A_core`) — but raised risk of cancer (OR = 1.11, 95% CI: 1.06-1.16) doi=10.1111/acel.13017
- `fact_id=145145` (`A_core`) — one SD TL decrement-associated hazard ratio of 1.09 (95% CI: 1.06-1.13) doi=10.1016/j.arr.2018.09.002
- `fact_id=172806` (`A_core`) — Variant status was significantly associated with transplant-free survival (discovery: age-, sex-, and ancestry-adjusted hazard ratio, 3.73) doi=10.1164/rccm.201902-0360oc
- `fact_id=172432` (`A_core`) — longer LTL was associated with higher brain volume (β = 0.43, 95%CI: 0.36-0.50%, p = 0.008, N = 1102) doi=10.1016/j.arr.2022.101679
- `fact_id=3475` (`A_core`) — In the comparison of the longest versus shortest third of TL, we observed a marginally positive association between longer TL and higher risk of total cancers [OR = 1.086; 95% CI, 0.952-1.238]. doi=10.1158/1055-9965.epi-16-0968

## What this changes

Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and matched direct-receipt table by population, model, endpoint, comparator, and effect direction that could confirm or kill the thesis.

## Limitations

- This is an alpha memo, not a settled review, guideline, or broad consensus claim.
- This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## What would weaken this

- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## Strongest counter-evidence

- _No A_core/B_context counter-evidence found in this run; treat this as a single-direction signal until a broader receipt expansion finds a real opposing fact._

## Next extraction

- Extract independent A_core/B_context receipts that test the lead contrast directly.
- Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.

## Provenance / priority

- **Topic:** `telomere`
- **Author:** Dom Lynch
- **ORCID:** _not configured_
- **Version:** 1.0
- **License:** CC BY-NC 4.0
- **Canonical URL:** _not assigned_
- **Suggested citation:** Dom Lynch. (2026). The Telomere Length Trade-off: Simultaneous Cardioprotection and Carcinogenesis in UK Biobank Elderly. ReseaRka Evidence Index. Version 1.0.
- **Run bundle SHA-256:** `de0753fe2c941bb7cc0c986379253cc3aa423857d47a2c986aace901cbb17d42`
- **Memo SHA-256:** `c02e04498f174309b3a64d195ab841c83009bcefd394e076424daaf5f495343b`
- **Priority note:** This memo records the first published framing, source bundle, and evidence receipts for this run. Reuse should cite the canonical version.

{
  "article_type": "alpha_memo",
  "domain_slug": "general",
  "researka_object_type": "submission",
  "researka_submission_id": "77c0d002-632a-4dc0-9d0f-9843c8972c54",
  "title": "The Telomere Length Trade-off: Simultaneous Cardioprotection and Carcinogenesis in UK Biobank Elderly"
}